• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Afro-Egyptian Journal of Infectious and Endemic Diseases
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 15 (2025)
Volume Volume 14 (2024)
Volume Volume 13 (2023)
Volume Volume 12 (2022)
Volume Volume 11 (2021)
Volume Volume 10 (2020)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 9 (2019)
Volume Volume 8 (2018)
Volume Volume 7 (2017)
Volume Volume 6 (2016)
Volume Volume 5 (2015)
Volume Volume 4 (2014)
Volume Volume 3 (2013)
Volume Volume 2 (2012)
Volume Volume 1 (2011)
Nada, A., Sabry, A., Elabd, N., Elbahr, O. (2020). The Gamma-glutamyl Transpeptidase to Platelet Ratio (GPR) Predict Significant Liver Fibrosis and Cirrhosis in Chronic Egyptian HCV Patients. Afro-Egyptian Journal of Infectious and Endemic Diseases, 10(2), 226-232. doi: 10.21608/aeji.2020.27598.1068
Ali Nada; Aliaa Sabry; Naglaa S Elabd; Osama Elbahr. "The Gamma-glutamyl Transpeptidase to Platelet Ratio (GPR) Predict Significant Liver Fibrosis and Cirrhosis in Chronic Egyptian HCV Patients". Afro-Egyptian Journal of Infectious and Endemic Diseases, 10, 2, 2020, 226-232. doi: 10.21608/aeji.2020.27598.1068
Nada, A., Sabry, A., Elabd, N., Elbahr, O. (2020). 'The Gamma-glutamyl Transpeptidase to Platelet Ratio (GPR) Predict Significant Liver Fibrosis and Cirrhosis in Chronic Egyptian HCV Patients', Afro-Egyptian Journal of Infectious and Endemic Diseases, 10(2), pp. 226-232. doi: 10.21608/aeji.2020.27598.1068
Nada, A., Sabry, A., Elabd, N., Elbahr, O. The Gamma-glutamyl Transpeptidase to Platelet Ratio (GPR) Predict Significant Liver Fibrosis and Cirrhosis in Chronic Egyptian HCV Patients. Afro-Egyptian Journal of Infectious and Endemic Diseases, 2020; 10(2): 226-232. doi: 10.21608/aeji.2020.27598.1068

The Gamma-glutamyl Transpeptidase to Platelet Ratio (GPR) Predict Significant Liver Fibrosis and Cirrhosis in Chronic Egyptian HCV Patients

Article 23, Volume 10, Issue 2, June 2020, Page 226-232  XML PDF (672.07 K)
Document Type: Original Article
DOI: 10.21608/aeji.2020.27598.1068
View on SCiNiTO View on SCiNiTO
Authors
Ali Nadaorcid 1; Aliaa Sabry1; Naglaa S Elabd email orcid 2; Osama Elbahr1
1Hepatology and Gastroenterology, National Liver Institute, Menoufia university, Menoufia Egypt
2Department of Tropical Medicine, Faculty of Medicine, Menoufia University, Menoufia, Egypt
Abstract
Background and aim: Non- invasive parameters of liver fibrosis are being widely incorporated and adopted in clinical practice, of them, 2 ratios APRI and FIB-4 were proposed and applied. The gamma-glutamyl transferase -to- platelet ratio (GPR) was developed and investigated as available test that is useful in predicting liver fibrosis stages in chronic HBV patients. We aimed to estimate the diagnostic performance of GPR compared to APRI in assessing different fibrosis stages estimated by ultrasound based Transient Elastography in chronic HCV Egyptian patients.
Methods: This prospective study was conducted on 90 treatment-naive chronic HCV patients. Fibrosis stages were assessed by Transient Elastography. Serum aspartate transferase, alanine transferase, gamma-glutamyl transferase and platelets were estimated. APRI and GPR formulas were calculated.
Results: GPR was significantly different with fibrosis stage (p value <0.001) in addition, higher GPR values associated with increasing fibrosis stage. The mean ± SD for GPR, APRI were 0.4 ± 0.31 and 0.38 ± 0.34 respectively. The AUROC of the GPR and APRI in predicting significant fibrosis (>F3) from non-significant fibrosis (< F3) was significant with GPR AUC was 0.97 while APRI AUC was 0.86. GPR at cutoff point 0.31 has sensitivity 92 %, specificity 88%, PPV 86 % and NPV 91 %. While, APRI at cutoff 0.26 has sensitivity 81 % and specificity 78 %.
Conclusion: The GPR represents a simple, non-invasive, inexpensive model for assessment of liver fibrosis. The GPR is a more accurate model than APRI to stage liver fibrosis in chronic HCV patients in Egypt.
Keywords
chronic HCV; liver fibrosis; non invasive test
Main Subjects
Hepatology
Statistics
Article View: 434
PDF Download: 498
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.